Marked increases in concentrations of apolipoprotein in the cerebrospinal fluid of poliovirus-infected macaques: relations between apolipoprotein concentrations and severity of brain injury.
Apolipoproteins in cerebrospinal fluid (CSF) might have important functional roles in the pathophysiology of brain and lipid metabolism in the vascular component. The present study examined apolipoprotein A-I (apo-A-I) and apolipoprotein E (apo-E) levels in CSF and serum from poliovirus-infected macaques. Poliovirus-infected macaques developed motor deficits and were classified into three groups: (1) muscle weakness in one or both legs; (2) partial paralysis in one or both legs; (3) complete paralysis in one or both legs. No motor deficits were evident in the control or sham-treated macaques. Apo-A-I concentrations in CSF were markedly elevated in poliovirus-infected macaques with weakness, partial or complete paralysis, in comparison with either control or sham-treated animals, and were proportional to the severity of motor impairment. Apo-E concentrations in CSF were also significantly elevated in poliovirus-infected macaques with complete paralysis. The magnitude of increase in CSF apo-A-I or apo-E concentrations was also closely associated with the degree of histologic neurological damage and inflammation (lesion scores). However, no changes in serum apo-A-I and apo-E concentrations were observed in the poliovirus-infected macaques compared with control macaques. Furthermore there were no significant correlations apo-A-I or apo-E concentrations between serum and CSF. We hypothesize that the elevation of apo-A-I and apo-E concentrations after poliovirus infection is caused by immune stimulation within the central nervous system (CNS). Measures of CSF apo-A-I and apo-E levels might serve as a useful marker for the severity and/or the range of CNS injury.
Saito
K
K
Department of Laboratory Medicine, Gifu University School of Medicine, Japan.
Seishima
M
M
Heyes
M P
MP
Song
H
H
Fujigaki
S
S
Maeda
S
S
Vickers
J H
JH
Noma
A
A
D000818:Animals; D000918:Antibody Specificity; D016632:Apolipoprotein A-I / Q000134:cerebrospinal fluid; D001053:Apolipoproteins / Q000134:cerebrospinal fluid*; D001057:Apolipoproteins E / Q000134:cerebrospinal fluid; D015153:Blotting, Western; D001930:Brain Injuries / Q000134:cerebrospinal fluid*; D008253:Macaca mulatta; D011051:Poliomyelitis / Q000134:cerebrospinal fluid*
D016632:Apolipoprotein A-I; D001053:Apolipoproteins; D001057:Apolipoproteins E